Navigating Immune-Related Adverse Events With Nivolumab in Upper GI Cancer
Experts discuss key immune-related adverse events (irAEs) to monitor in patients receiving nivolumab, how to differentiate these from disease-related symptoms, and how to manage moderate to severe irAEs, including factors that determine whether immunotherapy should be paused or discontinued.
Video content above is prompted by the following:
• What are the key irAEs to monitor in patients receiving nivolumab, and how do you differentiate these from disease-related symptoms ?
• How do you approach the management of moderate to severe irAEs, and what factors determine whether immunotherapy should be paused or discontinued?
Oncology Nurses Provide Patients an Avenue to Supportive Care
August 1st 2025Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
August 1st 2025Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
